Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
JCI Insight ; 1(20): e87446, 2016 12 08.
Artigo em Inglês | MEDLINE | ID: mdl-27942582

RESUMO

Pentraxin-2 (PTX-2), also known as serum amyloid P component (SAP/APCS), is a constitutive, antiinflammatory, innate immune plasma protein whose circulating level is decreased in chronic human fibrotic diseases. Here we show that recombinant human PTX-2 (rhPTX-2) retards progression of chronic kidney disease in Col4a3 mutant mice with Alport syndrome, reducing blood markers of kidney failure, enhancing lifespan by 20%, and improving histological signs of disease. Exogenously delivered rhPTX-2 was detected in macrophages but also in tubular epithelial cells, where it counteracted macrophage activation and was cytoprotective for the epithelium. Computational analysis of genes regulated by rhPTX-2 identified the transcriptional regulator c-Jun along with its activator protein-1 (AP-1) binding partners as a central target for the function of rhPTX-2. Accordingly, PTX-2 attenuates c-Jun and AP-1 activity, and reduces expression of AP-1-dependent inflammatory genes in both monocytes and epithelium. Our studies therefore identify rhPTX-2 as a potential therapy for chronic fibrotic disease of the kidney and an important inhibitor of pathological c-Jun signaling in this setting.


Assuntos
Proteína C-Reativa/farmacologia , Rim/patologia , Nefrite Hereditária/terapia , Proteínas do Tecido Nervoso/farmacologia , Proteínas Proto-Oncogênicas c-jun/antagonistas & inibidores , Transdução de Sinais , Fator de Transcrição AP-1/antagonistas & inibidores , Animais , Células Cultivadas , Fibrose , Humanos , Ativação de Macrófagos , Camundongos , Camundongos da Linhagem 129 , Camundongos Knockout , Monócitos , Nefrite Hereditária/patologia , Proteínas Recombinantes/farmacologia
2.
Am J Reprod Immunol ; 54(6): 352-7, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16305660

RESUMO

PROBLEM: Erythrocyte complement receptor type 1 (E-CR1) is the main immune complex clearance mechanism in humans. Decreased E-CR1 expression is noted in certain inflammatory disorders. Recent evidence implicates inflammation in the pathogenesis of preeclampsia. We investigated whether E-CR1 is decreased in preeclampsia. METHOD OF STUDY: E-CR1 protein expression was quantified by radioimmunoassay. Plasma concentration of soluble CR1 was quantified using a specific enzyme linked immunosorbent assay. Quantitative genotypes were evaluated by HindIII restriction fragment length polymorphism analysis. RESULTS: E-CR1 expression was reduced in patients with preeclampsia. Lack of neoantigen expression (indicative of enzymatic cleavage of CR1) or elevated plasma-soluble CR1 was evidence against an acquired loss of E-CR1. Genotype analysis revealed a higher frequency of a CR1 allele associated with low E-CR1 expression in preeclampsia when compared with normal pregnant controls. CONCLUSIONS: E-CR1 expression is decreased in preeclamptic patients and levels correlate with severity of disease. This condition may have a genetic basis in some patients.


Assuntos
Eritrócitos/imunologia , Pré-Eclâmpsia/diagnóstico , Receptores de Complemento 3b/biossíntese , Eritrócitos/metabolismo , Feminino , Humanos , Peptídeo Hidrolases/imunologia , Peptídeo Hidrolases/farmacologia , Polimorfismo de Fragmento de Restrição , Pré-Eclâmpsia/sangue , Gravidez , Receptores de Complemento 3b/deficiência , Receptores de Complemento 3b/genética
3.
Chem Biol ; 11(2): 185-94, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15123280

RESUMO

Genomics-driven growth in the number of enzymes of unknown function has created a need for better strategies to characterize them. Since enzyme inhibitors have traditionally served this purpose, we present here an efficient systems-based inhibitor design strategy, enabled by bioinformatic and NMR structural developments. First, we parse the oxidoreductase gene family into structural subfamilies termed pharmacofamilies, which share pharmacophore features in their cofactor binding sites. Then we identify a ligand for this site and use NMR-based binding site mapping (NMR SOLVE) to determine where to extend a combinatorial library, such that diversity elements are directed into the adjacent substrate site. The cofactor mimic is reused in the library in a manner that parallels the reuse of cofactor domains in the oxidoreductase gene family. A library designed in this manner yielded specific inhibitors for multiple oxidoreductases.


Assuntos
Desenho de Fármacos , Inibidores Enzimáticos/química , Oxirredutases/antagonistas & inibidores , Proteômica/métodos , Animais , Sítios de Ligação , Biologia Computacional , Biblioteca Gênica , Ligantes , Espectroscopia de Ressonância Magnética , Mimetismo Molecular , NADH NADPH Oxirredutases/antagonistas & inibidores , NADH NADPH Oxirredutases/química , NADH NADPH Oxirredutases/farmacologia , Oxirredutases/genética , Oxirredutases/farmacologia , Termodinâmica
4.
J Proteome Res ; 2(6): 626-32, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14692456

RESUMO

Enzymes that utilize nicotinamide adenine dinucleotide (NAD) or its 2'-phosphate derivative (NADP) are found throughout the kingdoms of life. These enzymes are fundamental to many biochemical pathways, including central intermediary metabolism and mechanisms for cell survival and defense. The complete genomes of 25 organisms representing bacteria, protists, fungi, plants, and animals, and 811 viruses, were mined to identify and classify NAD(P)-dependent enzymes. An average of 3.4% of the proteins in these genomes was categorized as NAD(P)-utilizing proteins, with highest prevalence in the medium-chain oxidoreductase and short-chain oxidoreductase families. In general, the distribution of these enzymes by oxidoreductase family was correlated to the number of different catalytic mechanisms in each family. Organisms with smaller genomes encoded a larger proportion of NAD(P)-dependent enzymes in their proteome (approximately 6%) as compared to the larger genomes of eukaryotes (approximately 3%). Among viruses, those with large, double-strand DNA genomes were shown to encode oxidoreductases. Gram-positive and gram-negative bacteria showed some differences in the distribution of NAD(P)-dependent proteins. Several organisms such as M. tuberculosis, P. falciparum, and A. thaliana showed unique distributions of oxidoreductases corresponding to some phenotypic features.


Assuntos
Células Eucarióticas/enzimologia , Genoma , Oxirredutases/classificação , Oxirredutases/genética , Células Procarióticas/enzimologia , Proteínas Virais/classificação , Animais , Bases de Dados de Proteínas , NADP/metabolismo , Oxirredutases/metabolismo , Proteínas Virais/genética , Proteínas Virais/metabolismo
5.
Proteins ; 50(4): 589-99, 2003 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-12577265

RESUMO

A novel method to organize protein structural information based solely on sequence is presented. The method clusters proteins into families that correlate with the three-dimensional protein structure and the conformation of the bound ligands. This procedure was applied to nicotinamide adenine dinucleotide [NAD(P)]-utilizing enzymes to identify a total of 94 sequence families, 53 of which are structurally characterized. Each of the structurally characterized proteins within a sequence family correlates to a single protein fold and to a common bound conformation of NAD(P). A wide range of structural folds is identified that recognize NAD(P), including Rossmann folds and beta/alpha barrels. The defined sequence families can be used to identify the type and prevalence of NAD(P)-utilizing enzymes in the proteomes of sequenced organisms. The proteome of Mycobacterium tuberculosis was mined to generate a proteome-wide profile of NAD(P)-utilizing enzymes coded by this organism. This enzyme family comprises approximately 6% of the open reading frames, with the largest subgroup being the Rossmann fold, short-chain dehydrogenases. The preponderance of short-chain dehydrogenases correlates strongly with the phenotype of M. tuberculosis, which is characterized as having one of the most complex prokaryotic cell walls.


Assuntos
Enzimas/química , Enzimas/metabolismo , NADP/metabolismo , Análise de Sequência de Proteína/métodos , Sequência de Aminoácidos , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Sítios de Ligação , Análise por Conglomerados , Enzimas/classificação , Flavinas/metabolismo , Frequência do Gene , Genoma Bacteriano , Ligantes , Modelos Moleculares , Mycobacterium tuberculosis/enzimologia , Mycobacterium tuberculosis/genética , NADP/química , NADPH Desidrogenase/química , Oxirredutases/química , Oxirredutases/genética , Oxirredutases/fisiologia , Conformação Proteica , Dobramento de Proteína , Proteínas/química , Proteínas/classificação , Proteínas/metabolismo , Proteoma/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...